Results 221 to 230 of about 1,205,764 (269)

Subjective Awareness of Abnormal Involuntary Movements in Schizophrenia

International Journal of Neuroscience, 1993
A wide majority of schizophrenic patients with Tardive dyskinesia, a neurological disorder produced by chronic neuroleptic therapy, lack awareness of their involuntary movements. This by contrast to patients with Parkinsonism who usually are aware of their abnormal movements. In the following communication we present a series of studies which are aimed
R, Sandyk, S R, Kay, G I, Awerbuch
openaire   +2 more sources

The trial use of clozapine for abnormal involuntary movement disorders

American Journal of Psychiatry, 1979
Twelve patients with abnormal involuntary movement disorders were treated with clozapine in a double-blind, placebo-controlled trial. The cohort consisted of individuals with Gilles de la Tourette's syndrome, Huntington's disease, and atypical persistent dyskinesia that was drug induced. Two subjects were dropped from the protocol due to complications.
E D, Caine, R J, Polinsky, R, Kartzinel, M H, Ebert   +3 more
openaire   +2 more sources

Predictors of Abnormal Involuntary Movement in an African Schizophrenia Population

Journal of Neuropsychiatry, 2008
As little is known about the risk factors for abnormal involuntary movements in African patients with schizophrenia, 170 Xhosa participants with schizophrenia were rated with the abnormal involuntary movement scale. Abnormal involuntary movements occurred in 19.4% of this group.
Dana J H, Niehaus, Stan A, du Plessis, Liezl, Koen, Barbara H, Lategan, Janus, Steyn, Petrus P, Oosthuizen, Louise, Warnich, Robin A, Emsley   +7 more
openaire   +2 more sources

ABNORMAL INVOLUNTARY MOVEMENTS INDUCED BY ANTICHOLINERGIC THERAPY

Acta Neurologica Scandinavica, 2009
Six patients developed abnormal involuntary movements during treatment with centrally active anticholinergic agents. Four of the patients had Parkinson's disease, and two had non-parkinsonian tremors. In all the cases the involuntary movements comprised bucco-linguo-masticatory dyskinesias, and in two, involuntary movements of the limbs as well.
openaire   +2 more sources

The Prevalence of Abnormal Involuntary Movements among Chronic Schizophrenic

International Clinical Psychopharmacology, 1986
In an international survey of chronic schizophrenia, data were collected on the Abnormal Involuntary Movements Scale (AIMS) to ascertain the prevalence of tardive dyskinesia. Abnormal movements were found to present in 28% of the sample of 739 patients.
W, Guy, T A, Ban, W H, Wilson
openaire   +2 more sources

Pathophysiology of L-Dopa-Induced Abnormal Involuntary Movements

1985
Among the various deficiencies in neurotransmitters and neuropeptides in the brains of patients with Parkinson's disease, the loss of dopamine (DA) is implicated in a major way in the occurrence of L-dopa-induced abnormal involuntary movements (AIMs). Whatever the clinical pattern, they are triggered by drugs which stimulate DA transmission and can be ...
Y, Agid, A M, Bonnet, M, Ruberg, F, Javoy-Agid   +3 more
openaire   +2 more sources

Correlates of the Abnormal Involuntary Movement Scale in Veterans With Tardive Dyskinesia

Journal of Clinical Psychopharmacology, 2020
Abstract Purpose/Background To add to limited evidence on the Abnormal Involuntary Movement Scale (AIMS) as a measure of tardive dyskinesia (TD) in clinical practice settings, the characteristics and correlates of AIMS scores were assessed. Methods/Procedures Veterans with
Stanley N, Caroff, Shirley H, Leong, Christopher B, Roberts, Rosalind M, Berkowitz, E Cabrina, Campbell   +4 more
openaire   +2 more sources

Subjective awareness of abnormal involuntary movements in chronic schizophrenic patients

American Journal of Psychiatry, 1990
The authors examined the effects of verbal and visual feedback on subjective awareness of involuntary movements in 20 chronic schizophrenic patients. At initial evaluation only 25% of the patients were fully aware of their movement disorder. Both verbal and visual feedback resulted in significant immediate enhancement of awareness.
G, Caracci, S, Mukherjee, S D, Roth, P, Decina   +3 more
openaire   +2 more sources

ABNORMAL INVOLUNTARY MOVEMENTS IN RELATION TO ANTICHOLINERGICS AND LEVODOPA THERAPY

Acta Neurologica Scandinavica, 1975
During a study comparing levodopa with and without benserazide in Parkinsonism, 19 of 41 patients (42 per cent) receiving concomitant anticholinergic therapy developed abnormal involuntary movements (AIM), in contrast to 11 of 58 patients (19 per cent) receiving only levodopa. This difference is statistically significant.
openaire   +2 more sources

Chronic Treatment with Talipexole Dihydrochloride on Abnormal Involuntary Movement in Humans

Clinical Neuropharmacology, 1990
Two cases of severe dystonia and dyskinesia were treated with talipexole, a dopamine autoreceptor agonist, and the metabolites of dopamine, norepinephrine, and serotonin in cerebrospinal fluid (CSF) were determined. Despite significant reductions in these metabolites in CSF, behavioral amelioration of these cases could not be observed.
T, Nishikawa, S, Yamada, A, Tsuda, M, Tanaka, I, Koga, Y, Uchida   +5 more
openaire   +2 more sources